Foster City, CA, United States of America

Jeanne F Loring


Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1999-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jeanne F Loring: Innovator in Alzheimer's Research

Introduction

Jeanne F Loring is a prominent inventor based in Foster City, CA, known for her significant contributions to the field of neuroscience, particularly in Alzheimer's disease research. With a total of four patents to her name, Loring has made strides in understanding and diagnosing brain disorders.

Latest Patents

Among her latest patents is a composition comprising a plurality of cDNAs that are differentially expressed in disorders of the brain, particularly Alzheimer's disease. This invention may be utilized in its entirety or in part to diagnose, stage, treat, or monitor the treatment of subjects with brain disorders. Another notable patent is for a bigenic mouse that expresses the human tau gene. This mouse model is designed to contain inactive mouse TAU genes and a transgene encoding the human TAU gene, which is essential for neuronal expression. These mice serve as valuable models for studying Alzheimer's, Frontal Temporal Dementia, and Parkinson's-like diseases.

Career Highlights

Throughout her career, Jeanne F Loring has worked with several companies, including Genpharm International, Inc. and Cognosci, Incorporated. Her work has been instrumental in advancing research in neurodegenerative diseases and has garnered attention in the scientific community.

Collaborations

Loring has collaborated with notable colleagues such as Debora W Tingley and Carla M Edwards, contributing to a rich exchange of ideas and research in her field.

Conclusion

Jeanne F Loring's innovative work in Alzheimer's research and her development of valuable models for studying brain disorders highlight her significant impact on neuroscience. Her contributions continue to pave the way for advancements in understanding and treating neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…